This post was originally published on this site
Original post: Newswise - Drug and Drug Abuse Nationwide Clinical Study Expands Platform to Test Medications to Treat Mild-to-Moderate COVID-19
A study led by the Duke Clinical Research Institute has expanded its testing platform to evaluate three repurposed medications in the search for effective, safe treatments for mild-to-moderate COVID-19. Repurposed medications are those already approved by the U.S. Food and Drug Administration for other indications.